Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.04 is 44% above its 5-year average of 5.58, around the middle of its 5-year range (0.40–16.83).
As of the fiscal period ended Tuesday, June 30, 2026. 16.44% below its 12-month average of 9.62.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.04.
QUICK RATIO (ACID-TEST)
8.04
QUICK RATIO (ACID-TEST) AVG TTM
9.62
QUICK RATIO (ACID-TEST) AVG 3Y
6.61
QUICK RATIO (ACID-TEST) AVG 5Y
5.58
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.44%
CURRENT VS 3Y AVG
+21.53%
CURRENT VS 5Y AVG
+44.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+139.52%
vs the sector median at left
Alpha Cognition Inc
Market Cap
$139.47M
Quick Ratio (Acid-Test)
8.04
TTM Avg
9.62
3Y Avg
6.61
5Y Avg
5.58
Market Cap
$139.84M
Quick Ratio (Acid-Test)
3.32
TTM Avg
2.30
3Y Avg
3.60
5Y Avg
5.41
Market Cap
$139.04M
Quick Ratio (Acid-Test)
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$137.80M
Quick Ratio (Acid-Test)
2.09
TTM Avg
2.13
3Y Avg
2.85
5Y Avg
4.38
Market Cap
$136.67M
Quick Ratio (Acid-Test)
8.73
TTM Avg
6.53
3Y Avg
6.53
5Y Avg
6.53
Market Cap
$136.57M
Quick Ratio (Acid-Test)
1.07
TTM Avg
2.33
3Y Avg
2.66
5Y Avg
3.76
Market Cap
$143.60M
Quick Ratio (Acid-Test)
10.97
TTM Avg
15.14
3Y Avg
14.07
5Y Avg
22.68
Market Cap
$143.84M
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $139.47M | 8.04 | 9.62 | 6.61 | 5.58 |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | 3.32 | 2.30 | 3.60 | 5.41 |
| Immuneering Corporation (IMRX)vs › | $139.04M | 19.47 | 11.39 | 11.91 | 15.23 |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 2.09 | 2.13 | 2.85 | 4.38 |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | 8.73 | 6.53 | 6.53 | 6.53 |
| Organigram Global Inc. (OGI)vs › | $136.57M | 1.07 | 2.33 | 2.66 | 3.76 |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 2.31 | 2.75 | 4.17 | 7.24 |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 10.97 | 15.14 | 14.07 | 22.68 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 1.23 | 1.14 | 1.35 | 4.96 |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
Quick Ratio
8.04
Excludes inventory
Current Ratio
9.03
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.04 |
| 2026-03-31 | 11.52 |
| 2025-12-31 | 8.09 |
| 2025-09-30 | 6.03 |
| 2025-06-30 | 14.40 |
| 2025-03-31 | 16.83 |
| 2024-12-31 | 14.81 |
| 2024-09-30 | 1.50 |
| 2024-06-30 | 0.96 |
| 2024-03-31 | 1.32 |
| 2023-12-31 | 0.73 |
| 2023-09-30 | 0.40 |
| 2023-06-30 | 1.32 |
| 2023-03-31 | 2.04 |
| 2022-12-31 | 0.58 |
| 2022-09-30 | 1.66 |
| 2022-06-30 | 3.08 |
| 2022-03-31 | 5.29 |
| 2021-12-31 | 6.75 |
| 2021-09-30 | 5.73 |
| 2021-06-30 | 5.99 |
| 2021-03-31 | 11.57 |
| 2021-01-31 | 2.15 |
| 2020-01-31 | 0.00 |
| 2019-10-31 | 0.00 |
| 2019-07-31 | 0.00 |
| 2019-04-30 | 0.00 |
| 2019-01-31 | 0.00 |
| 2018-10-31 | 0.00 |
